Dr. Simon Sumer explains how AI‑driven protein design is shortening development cycles, improving screening efficiency, and ...
OpenProtein.AI is helping biologists stay on the cutting edge of AI with a no-code platform for protein engineering.
Artificial intelligence is already proving it can accelerate drug development and improve our understanding of disease. But ...
Multiple research fronts saw major advances on April 24, 2026, with AI models driving new capabilities in protein interaction prediction, automated protein design, and earthquake engineering ...
Researchers led by Professor Zhang Yang, Senior Principal Investigator from the Cancer Science Institute of Singapore (CSI ...
This review examines how high-throughput proteomics is expanding precision medicine by improving biomarker discovery, disease ...
10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.
AI is accelerating protein design by enhancing structure prediction, candidate screening, and downstream analysis, enabling faster and more consistent results. Automation complements these advances by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results